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Antitumor compoundsAbstract Compounds with either ionone or chalcone skeletons present many biological properties
including anticancer activity. Here we have prepared eight terpenoid-like chalcones in order to
assess whether hybrid compounds with both structural frameworks could exhibit enhanced pharma-
cological proﬁle. The terpenoid-like chalcones were synthesized by means of Claisen–Schmidt con-
densation reaction, using either a- or b-ionone with substituted benzaldehydes. The structure of six
derivatives was elucidated by single crystal X-ray diffraction technique for the ﬁrst time. Cyclohex-
ene ring adopts half-chair conformation in a-ionone-derived chalcone with quaternary carbon at
the ﬂap, while twist puckering was observed in b-ionone terpenoid-like chalcones. All prepared
compounds were tested for their cytotoxic activity against three cancer cell lines, namely SF-295,
HCT-116 and OVCAR-8, which allowed us to establish some structure–activity relationships.
Terpenoid-like chalcones with nitro substituted phenyl rings, regardless of its position and ionone
type, were the most active chalcones among all that tested. The IC50 values do also reveal a trend of
decrease in cytotoxic activity with weak electron-withdrawing groups at phenyl ring.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Chalcones and their derivatives have a great pharmaceutical relevance
(Bukhari et al., 2012) due the fact that they are used as ameliorative
(Sarojini et al., 2011), inhibitors of nitric oxide production, cytotoxic
agents (Reddy et al., 2012), antimicrobial (Asiri and Khan, 2011;
Bukhari et al., 2013a), anti-inﬂammatory (Bukhari et al., 2013b,
2014b, 2015; Jantan et al., 2014), anticancer (Modzelewska et al.,
2006), antimalarial (Srivastava et al., 2008), antiviral agents and UV
radiation protectors (Raj et al., 2012).//dx.doi.
2 R.S. Lima et al.Compounds with the trimethylcyclohexene moiety are responsible
for the aroma of essential oils and therefore they have attracted atten-
tion of fragrance and ﬂavor industries. Among these compounds,
ionones and their derivatives are raw materials for synthesis of many
natural products and intermediates in the metabolism of terpenoids
(for instance, in the carotenoid biosynthesis). In addition, these com-
pounds have been isolated from many natural sources (Lutz-Wall
et al., 1998). Furthermore, derivatives of ionones (e.g., 3-hydroxy-b-
ionone) are valuable intermediates for the chemical-enzymatic synthe-
sis of carotenoids such as astaxanthin and zeaxanthin (Markovich
et al., 1998). b-ionone is used as starting material in the synthesis of
vitamin A (retinol). Additionally, some ionone derivatives have shown
several biological activities (Raynaud et al., 2006; Chandra et al., 2006;
Suryawanshi et al., 2007). As an example, we can cite an aryl-
substituted pyrimidine terpenoid-like derivative with leishmanicidal
activity (Chandra et al., 2006).
Structurally, chalcones have the same pharmacophore found in ﬂa-
vones and isoﬂavones, which are potent inhibitors of DNA topoiso-
merase II and therefore are considered as potent antitumor and anti-
HIV agents (Wang et al., 1997). Recently, chalcone analogs with three
substituted aromatic rings have demonstrated potent NO and reactive
oxygen species (ROS) production inhibition and cytotoxic properties
(Bukhari et al., 2014c; Reddy et al., 2012).
Based on the known biological properties of compounds with
either ionone or chalcone skeletons, including anticancer activity, we
have prepared eight terpenoid-like chalcones in order to assess whether
hybrid compounds with both structural frameworks could exhibit
enhanced pharmacological proﬁle due to synergism between them.
The terpenoid-like chalcones were synthesized by mean of Claisen–
Schmidt condensation reaction, using either a- or b-ionone with substi-
tuted benzaldehydes (Findik et al., 2009), as shown in Scheme 1, and
their structures were doubtless elucidated by single crystal X-ray
diffraction technique besides complementary methodologies such as
NMR. At last, all prepared compounds were tested for their cytotoxic
activity against three cancer cell lines, namely SF-295 (central nervous
system), HCT-116 (colon) and OVCAR-8 (breast cancer), which
allowed us to establish some structure–activity relationships.
2. Experimental
2.1. General procedure for synthesis of terpenoid-like chalcones
1–8
a-Ionone, b-ionone, and benzaldehyde derivatives were highest
reagent grade commercial products. A water solution of
sodium hydroxide (0.123 g) was added to mixture of ionone
(1.5 mmol) and benzaldehyde derivative (2.5 mmol) in metha-
nol (10 ml). The reaction mixture was stirred at room temper-
ature for 12 h. At the end of reaction time, the mixture was
diluted with CH2Cl2, treated with HCl solution (10%), and
washed with water. The organic phase was dried over anhy-
drous Na2SO4 and ﬁltered. The solvent was slowly evaporated
and the crystals suitable for structure determination were iso-
lated without further crystallization. Furthermore, the product
of the reaction was chromatographed on a silica gel column,
120–230 mesh, and eluted with ethyl acetate: hexane (2:8).
2.2. Structure determination by single-crystal X-ray diffraction
technique
Suitably shaped single crystals of 1, 3–8 were selected for the
X-ray diffraction data collection on a Bruker-AXS Kappa
Duo diffractometer with an APEX II CCD detector. Even
though compound 5 has been determined previously (ZouPlease cite this article in press as: Lima, R.S. et al., Structure and cytotoxic activity o
org/10.1016/j.arabjc.2016.02.013et al., 2012), we performed the collection of its single-crystal
X-ray data. Therefore, all geometrical parameters of 5 pre-
sented here are from our structure redetermination. We have
deposited crystal data of 5 with Cambridge Crystallographic
Data Centre (CCDC) under deposit code 1029769. Compound
2 was not redetermined in this study and its crystal data are
from the literature (CCDC deposit code 818053) (Fernandes
et al., 2013). Mo Ka radiation from an IlS microsource with
multilayer optics was employed. Diffraction images were
recorded by u and x scans set using APEX2 software
(Bruker, 2012). This software was also employed to treat the
raw dataset for indexing, integrating, reducing and scaling of
the reﬂections. Next, the crystallographic softwares were used
as follows: SIR2004 (structure solving) (Burla et al., 2005),
SHELXL-97 (structure reﬁnement) (Sheldrick, 2008), MER-
CURY and ORTEP-3 (structure analysis and representations)
(Macrae et al., 2008; Farrugia, 1997). All structures were
solved through identiﬁcation of all non-hydrogen atoms in
asymmetric units directly from the Fourier synthesis of the
structure factors after retrieval of their phase using the direct
methods. Each initial model was reﬁned by full-matrix least
squares method on F2, adopting free anisotropic and con-
strained isotropic atomic displacement parameters for non-
hydrogen and hydrogen atoms, respectively. In the case of
hydrogens, their Uiso was set to either 1.2Ueq of the bonded
carbon, except for methyl hydrogens in which their Uiso was
set to 1.5Ueq of the corresponding carbon. Hydrogen coordi-
nates were stereochemically deﬁned and constrained in the
reﬁnements, oscillating as that of the bonded carbon to keep
idealized bond angles and lengths ﬁxed in 0.93 A˚ (Csp
2 AH),
0.96 A˚ (Csp
3 AH in CH3 groups), 0.97 A˚ (Csp
3 AH in CH2
groups), and 0.98 A˚ (Csp
3 AH in CH groups).
Compounds 5–8 were present with two twist conformations
of the cyclohex-1-ene ring. This conformational variability has
occurred due to static disorder into the six-membered ring. The
static disorder was modeled by splitting the CH2 carbons and
hydrogens over two sites with occupancy factors constrained
to the following values: 50% (both conformations of 6),
55% (major conformation of 5 and 7 whose carbon fractions
were labeled as C14AC16), 65% (major conformation of 8
whose carbon fractions were labeled as C14AC16), 45%
(minor conformation of 5 and 7 whose carbon fractions were
labeled as C140AC160), or 35% (minor conformation of 8
whose carbon fractions were labeled as C140AC160). It is
important to state that all site occupancy factors (SOFs) of
these carbons were reﬁned freely in trial reﬁnements. The SOFs
found from initial reﬁnements were then constrained to the
corresponding sites and in sequence hydrogens were stereo-
chemically positioned using a riding model on carbon as
described above. Such reﬁnement procedure has resulted in
better R-factors, the lowest residual electronic density in the
unit cell and reﬁnement convergence. It is striking to note that
unusual values of R-factors were outputted from reﬁnement of
1 and 3, which could be a consequence of a static disorder due
to different cyclohex-2-ene ring puckering modes similar to
those modeled reliably for terpenoid-like chalcones 5–8. In
trial reﬁnements constraining the primary site occupancy of
cyclohex-2-ene carbon atoms to 50%, extra occupancy sites
were observed but they were very close together with the pri-
mary ones. In attempt to reﬁne them as carbon fractions, high
correlation between all tested SOFs and atomic displacement
parameters was observed applying the classical split-atomf terpenoid-like chalcones. Arabian Journal of Chemistry (2016), http://dx.doi.
Scheme 1 General scheme for synthesis of terpenoid-like chalcones studied here. Compounds 2 and 5 have been previously synthesized
and featured (Zou et al., 2012; Fernandes et al., 2013).
Terpenoid-like chalcones 3approach to the structural model of 1 and 3, as well as reﬁne-
ments were unstable without convergence. Therefore, we have
used the classical harmonic model based upon a development
of the atomic displacement parameters with just one site
instead of the split-position model.
2.3. Additional characterization
Other characterizations of synthesized compounds were per-
formed as follows. Melting points were measured in a Micro
Quı´mica MQAPF-301 apparatus. The infrared spectra were
obtained in Bomem M102 Fourier Transform spectrometer.
Samples were analyzed by the FTIR transmission technique
as KBr pellets (mixtures comprising 200 mg of KBr and 1 mg
of sample). NMR spectra were recorded on a Bruker Avance
III, operating at 500.13 MHz for 1H and 125.77 MHz for 13C,
equipped with a 5 mm TBI probe (1H, 13C and XBB).
2.3.1. (1E,4E)-1-(4-nitrophenyl)-5-(2,6,6-trimethylcyclohex-2-
en-1-yl)penta-1,4-dien-3-one
(1): Orange solid, 70% yield, mp 104–106 C. IR mmax 2944–
2822, 1668, 1605, 1518, 1435, 1342, 1278, 1211, 1186, 1113,
980, 856, 814, 757, 682. 1H NMR [500 MHz, d (ppm),
DMSO-d6]: 8.25 (d, 8.7 Hz, H-3/5), 8.06 (d, 8.7 Hz, H-2/6),
7.70 (d, 15.8 Hz, H-7), 7.56 (d, 15.8 Hz, H-8), 6.92 (dd, 15.4;
9.7 Hz, H-11), 6.45 (d, 15.4 Hz, H-10), 5.52 (br s, H-16), 2.40
(d, 9.7 Hz, H-12), 2.04 (m, H-15), 1.55 (m, H-14a), 1.20 (m,
H-14b), 1.56 (br d, H-20), 0.91 (s, H-18), 0.83 (s, H-19). 13C
NMR [125 MHz, d (ppm), DMSO-d6]: 187.6 (C-9), 149.2
(C-11), 147.8 (C-4), 141.2 (C-1), 139.7 (C-7), 131.6 (C-17),
130.8 (C-10), 129.6 (C-2/6), 127.8 (C-8), 123.7 (C-3/5), 122.0
(C-16), 53.9 (C-12), 32.5 (C-13), 30.4 (C-14), 27.5 (C-19), 26.3
(C-18), 22.6 (C-15), 22.4 (C-20).
2.3.2. (1E,4E)-1-(4-nitrophenyl)-5-(2,6,6-trimethylcyclohex-1-
en-1-yl)penta-1,4-dien-3-one
(2): Orange solid, 78% yield, mp 134–135 C. IR mmax 2923,
1663, 1615, 1591, 1512, 1454, 1416, 1343, 1247, 1198, 1144,Please cite this article in press as: Lima, R.S. et al., Structure and cytotoxic activity o
org/10.1016/j.arabjc.2016.02.0131090, 981, 861, 752, 716, 620. 1H NMR [500 MHz, d (ppm),
DMSO-d6]: 8.27 (d, 8.6 Hz, H-3/5), 8.05 (d, 8.6 Hz, H-2/6),
7.73 (d, 16.0 Hz, H-7), 7.52 (d, 16.0 Hz, H-11), 7.50 (d,
16.0 Hz, H-8), 6.59 (d, 16.0 Hz, H-10), 2.11 (m, H-16), 1.80
(s, H-20), 1.60 (m, H-15), 1.47 (m, H-14), 1.10 (s, H-18/19).
13C NMR [125 MHz, d (ppm), DMSO-d6]: 188.0 (C-9),
147.9 (C-4), 142.4 (C-7), 141.3 (C-1), 139.3 (C-11), 137.4
(C-17), 135.9 (C-12), 129.5 (C-6/8), 129.5 (C-2), 129.3 (C-10),
123.8 (C-3/5), 39.4 (C-14), 33.7 (C-13), 33.2 (C-16), 28.5
(C-18/19), 21.5 (C-20), 18.3 (C-15).
2.3.3. (1E,4E)-1-(3-nitrophenyl)-5-(2,6,6-trimethylcyclohex-2-
en-1-yl)penta-1,4-dien-3-one
(3): Yellow solid, 80% yield, mp 90–92 C. IR mmax 3090–2860,
1658, 1604, 1524, 1471, 1438,1353, 1283, 1252, 1209, 1134,
1092, 995, 947, 883, 829, 744, 696, 670, 578. 1H NMR
[500 MHz, d (ppm), DMSO-d6]: 8.63 (br t, 2.0 Hz, H-6), 8.26
(m, H-4), 8.25 (m, H-2), 7.77 (d, 15.9 Hz, H-7), 7.73 (t,
7.9 Hz, H-3), 7.57 (d, 15.9 Hz, H-8), 6.92 (dd, 15.4; 9.7 Hz,
H-11), 6.47 (dd, 15.4; 0.6 Hz, H-10), 5.53 (br s, H-16), 2.41
(d, 9.7 Hz, H-12), 2.05 (m, H-15), 1.57 (m, H-14a), 1.22 (m,
H-14b), 1.58 (br d, H-20), 0.92 (s, H-18), 0.85 (s, H-19). 13C
NMR [125 MHz, d (ppm), DMSO-d6]: 188.1 (C-9), 149.0
(C-11), 148.4 (C-5), 140.0 (C-7), 136.6 (C-1), 134.6 (C-2),
131.8 (C-17), 131.0 (C-10), 130.6 (C-3), 127.0 (C-8), 124.5
(C-4), 123.0 (C-6), 122.3 (C-16), 53.9 (C-12), 32.1 (C-13),
30.7 (C-14), 27.6 (C-19), 26.6 (C-18), 22.6 (C-15), 22.5 (C-20).
2.3.4. (1E,4E)-1-(3-nitrophenyl)-5-(2,6,6-trimethylcyclohex-1-
en-1-yl)penta-1,4-dien-3-one
(4): Yellow solid, 90% yield, mp 133–135 C. IR mmax 3090–
2863, 1662, 1596, 1536, 1457, 1349, 1307, 1205, 1168, 1096,
1030, 987, 921, 885, 818, 734, 691, 661, 565. 1H NMR
[500 MHz, d (ppm), DMSO-d6]: 8.62 (br t, 1.8 Hz, H-6), 8.24
(m, H-4), 8.23 (m, H-2), 7.77 (d, 16.0 Hz, H-7), 7.72 (t,
7.8 Hz, H-3), 7.51 (d, 16.0 Hz, H-8), 7.49 (d, 16.0 Hz, H-11),
6.61 (d, 16.0 Hz, H-10), 2.10 (m, H-16), 1.81 (s, H-20), 1.59
(m, H-15), 1.47 (m, H-14), 1.10 (s, H-18/19). 13C NMRf terpenoid-like chalcones. Arabian Journal of Chemistry (2016), http://dx.doi.
4 R.S. Lima et al.[125 MHz, d (ppm), DMSO-d6]: 188.0 (C-9), 148.1 (C-5), 142.2
(C-11), 139.6 (C-7), 137.5 (C-17), 136.6 (C-1), 135.9 (C-12),
134.4 (C-2), 130.2 (C-3), 129.1 (C-10), 128.4 (C-8), 124.3
(C-4), 122.9 (C-6), 39.2 (C-14), 33.5 (C-13), 33.1 (C-16), 28.5
(C-18/19), 21.4 (C-20), 18.3 (C-15).
2.3.5. (1E,4E)-1-(2-nitrophenyl)-5-(2,6,6-trimethylcyclohex-1-
en-1-yl)penta-1,4-dien-3-one
(5): Orange solid, 85% yield, mp 130–132 C. IR mmax
3098–2808, 1671, 1607, 1573, 1526, 1451, 1352, 1323, 1300,
1271, 1207, 1143, 1091, 981, 906, 865, 795, 749, 708, 639,
569. 1H NMR [500 MHz, d (ppm), DMSO-d6]: 8.06 (dd, 8.1;
1.2 Hz, H-5), 8.02 (dd, 7.8; 1.2 Hz, H-2), 7.88 (d, 16.0 Hz, H-
7), 7.80 (t, 7.8 Hz, H-3), 7.67 (t, 8.0 Hz, H-4), 7.50 (d,
16.0 Hz, H-11), 7.31 (d, 16.0 Hz, H-8), 6.54 (d, 16.0 Hz, H-
10), 2.10 (m, H-16), 1.81 (s, H-20), 1.59 (m, H-15), 1.46 (m,
H-14), 1.10 (s, H-18/19). 13C NMR [125 MHz, d (ppm),
DMSO-d6]: 188.0 (C-9), 148.6 (C-6), 143.2 (C-11), 137.6
(C-17), 136.8 (C-7), 135.7 (C-12), 133.9 (C-3), 133.7 (C-1),
130.2 (C-4), 129.7 (C-8), 129.6 (C-10), 129.1 (C-2), 124.8
(C-5), 39.4 (C-14), 33.5 (C-13), 32.8 (C-16), 28.4 (C-18/19),
21.4 (C-20), 18.1 (C-15).
2.3.6. (1E,4E)-1-(4-bromophenyl)-5-(2,6,6-trimethylcyclohex-
1-en-1-yl)penta-1,4-dien-3-one
(6): Yellow solid, 76% yield, mp 96–98 C. IR mmax 3080–2854,
1665, 1601, 1555, 1492, 1457, 1405, 1353, 1324, 1272, 1197,
1058, 995, 891, 844, 816, 717, 660, 585, 527, 492. 1H NMR
[500 MHz, d (ppm), DMSO-d6]: 7.73 (d, 8.3 Hz, H-3/5), 7.63
(d, 8.3 Hz, H-2/6), 7.61 (d, 15.8 Hz, H-7), 7.44 (d, 15.8 Hz,
H-11), 7.34 (d, 15.8 Hz, H-8), 6.55 (d, 15.8 Hz, H-10), 2.09
(br t, H-16), 1.79 (s, H-20), 1.60 (m, H-15), 1.47 (m, H-14),
1.09 (s, H-18/19). 13C NMR [125 MHz, d (ppm), DMSO-d6]:
188.1 (C-9), 141.8 (C-7), 140.8 (C-11), 136.7 (C-17), 136.0
(C-12), 134.0 (C-1), 131.8 (C-3/5), 130.4 (C-2/6), 129.5 (C-8),
126.5 (C-10), 123.6 (C-4), 39.4 (C-14), 33.7 (C-13), 33.1
(C-16), 28.6 (C-18/19), 21.5 (C-20), 18.4 (C-15).
2.3.7. (1E,4E)-1-(4-chlorophenyl)-5-(2,6,6-trimethylcyclohex-
1-en-1-yl)penta-1,4-dien-3-one
(7): Orange solid, 78% yield, mp 100–102 C. IR mmax 2969–
2871, 1654, 1603, 1494, 1447, 1402, 1321, 1194, 1085, 1016,
976, 884, 815, 781, 683, 631, 573, 499. 1H NMR [500 MHz, d
(ppm), DMSO-d6]: 7.81 (d, 8.7 Hz, H-2/6), 7.50 (d, 8.7 Hz,
H-3/5), 7.63 (d, 16.3 Hz, H-7), 7.44 (d, 16.3 Hz, H-11), 7.32
(d, 16.3 Hz, H-8), 6.55 (d, 16.3 Hz, H-10), 2.09 (br t, H-16),
1.79 (s, H-20), 1.59 (m, H-15), 1.47 (m, H-14), 1.09
(s, H-18/19). 13C NMR [125 MHz, d (ppm), DMSO-d6]:
188.8 (C-9), 142.5 (C-7), 141.4 (C-11), 137.4 (C-17), 136.7
(C-12), 135.5 (C-1), 134.4 (C-4), 131.0 (C-2/6), 130.2 (C-8),
129.6 (C-3/5), 127.2 (C-10), 40.1 (C-14), 34.5 (C-13), 33.9
(C-16), 29.3 (C-18/19), 22.3 (C-20), 19.1 (C-15).
2.3.8. (1E,4E)-1-(4-methylphenyl)-5-(2,6,6-trimethylcyclohex-
1-en-1-yl)penta-1,4-dien-3-one
(8): Yellow solid, 68% yield, mp 92–94 C. IR mmax. 1H NMR
[500 MHz, d (ppm), DMSO-d6]: 7.66 (d, 8.8 Hz, H-2/6), 7.62
(d, 16.0 Hz, H-7), 7.41 (d, 16.0 Hz, H-11), 7.25 (d, 8.8 Hz,
H-3/5), 7.23 (d, 16.0 Hz, H-8), 6.56 (d, 16.0 Hz, H-10), 2.09
(m, H-16), 1.79 (s, H-20), 1.59 (m, H-15), 1.47 (m, H-14),Please cite this article in press as: Lima, R.S. et al., Structure and cytotoxic activity o
org/10.1016/j.arabjc.2016.02.0131.09 (s, H-18/19). 13C NMR [125 MHz, d (ppm), DMSO-d6]:
188.1 (C-9), 142.2 (C-7), 141.3 (C-11), 140.4 (C-4), 136.3
(C-17), 135.9 (C-12), 132.0 (C-1), 129.5 (C-8), 129.5 (C-2/6),
128.5 (C-3/5), 124.9 (C-10), 39.4 (C-14), 33.7 (C-13), 33.1
(C-16), 28.6 (C-18/19), 21.0 (C-20), 18.4 (C-15).
2.4. Cytotoxicity assay
Terpenoid-like chalcones were tested for cytotoxicity against
three tumor cell lines: SF-295 (central nervous system),
HCT-116 (colon cancer) and OVCAR-8 (breast cancer). All
cell lines were obtained from National Cancer Institute
(NCI) (Skehan et al., 1990) and they are the ﬁrst choice cancer
cell lines used for the cytotoxicity screening in the Laborato´rio
de Oncologia from Universidade Federal of Ceara´, where the
assays were performed. These cancer cell lines were cultivated
in RPMI 1640 medium supplemented with fetal bovine serum
(10%), glutamine (2 mm), penicillin (100 U/ml), and strepto-
mycin (100 mg/ml), at 37 C, with CO2 (5%). The MTT assay
was used for the cytotoxicity evaluation of terpenoid-like chal-
cones (Berridge et al., 1996; Mossman, 1983). Cells were plated
at a concentration of 0.1  106 cells/ml for strains SF-295 and
OVCAR-8-3 and 0.7  105 cells/ml for the HCT-116 strain..
Doxorubicin (5 lg/ml) and DMSO (0.05%) were used as pos-
itive and negative controls, respectively. After 24 h, the
terpenoid-like chalcones were added to the wells to obtain
the ﬁnal concentration (25 lg/ml). After 72 h, plates were cen-
trifuged (1500 rpm, 15 min), and the supernatants were
removed. An aliquot (150 ll) from the MTT soln. (0.5 mg/
ml) was added into each well, and the plates were incubated
for 3 h under the same conditions described above. Then,
DMSO (150 ll) was poured to dissolve the precipitate, and
the absorbance was measured at 595 nm. This experiment
was run in three replicates, and all absorbance values were
converted into a cell growth inhibition percentage (GI-%) by
the following equation: GI-%= 100  [(T/C)  100%]. C is
the absorbance for the negative control, and T was the absor-
bance in the presence of the tested extract. Those compounds
that presented more than 85% of activity were selected to be
tested at concentrations varying from 0.078 to 5 lg/ml to
determine IC50 values by nonlinear regression using GraphPad
Prism 4.0 software.
3. Results and discussion
3.1. Conformational analysis from crystal structures
The terpenoid-like chalcones 1–8 were synthetized by Claisen–
Schmidt condensation reaction between a- and b-ionone with
substituted benzaldehydes dissolved in methanol (MeOH).
The reactions were catalyzed by sodium hydroxide (NaOH)
in aqueous solution at room temperature for 12 h. The struc-
ture of all compounds is presented in Scheme 1. All products
were characterized by melting point, infrared and NMR spec-
troscopy, and single-crystal X-ray diffraction technique.
Except for compounds 2 and 5, their crystal structure is
reported for the ﬁrst time here. In addition, we have also rede-
termined the structure of 5 in this study. Such structure rede-
termination allowed us to know correctly the population of
each cyclohexene twist conformation. Zou et al. (2012) havef terpenoid-like chalcones. Arabian Journal of Chemistry (2016), http://dx.doi.
Terpenoid-like chalcones 5wrongly modeled the disordered methylene groups of cyclo-
hexene over two sets of sites with occupancy ratios of
0.50:0.50 and 0.60:0.40. This does result obligatorily in an
unexpected planar cyclohexene conformation of 10% occu-
pancy in addition to the two expected twist conformations.
Furthermore, an extremely short Csp
3 ACsp
3 bond length is
observed in this planar conformation (according to Zou
et al. (2012) atom labeling scheme, C15AC160 measures
1.21 A˚). Therefore, our redetermination does correct the previ-
ous model to only two twist conformations of the cyclohexene
ring with either 55% or 45% occupancy. In our model, all
bond lengths into cyclohexene ring are also in agreement with
the expected values.
Here, structures of six terpenoid-like chalcones (1, 3, 4, 6–8)
have been elucidated by single-crystal X-ray diffraction tech-
nique for the ﬁrst time, while analogs 2 and 5 were already
determined crystallographically (Zou et al., 2012; Fernandes
et al., 2013) but their crystal data will be also presented here
for comparison purposes. Terpenoid-like chalcones 1–5 and
8 crystallized in centrosymmetric space groups as expected
from either the absence of chiral centers in their molecular
backbones (compounds 2, 4, 5 and 8) or achiral synthesis
(compounds 1 and 3) (Table 1). Even without molecular chiral-
ity, compounds 6 and 7 were solved in a noncentrosymmetric
space group as a consequence of frozen-in chirality upon crys-
tallization, i.e., just one conformation is assumed in the crystal
lattice.
The asymmetric unit of all terpenoid-like chalcones is com-
posed by just one molecule, even though cyclohexene ring can
adopt two puckering modes in a same structure which resulted
in disordered occupancy sites (Fig. 1).
As can be viewed in Fig. 1, a 30% probability ellipsoids rep-
resentation of the asymmetric units determined in this study,
the stereochemistry around both C7‚C8 and C10‚C11 dou-
ble bonds is unambiguously assigned as an (E)-conﬁguration.
In compounds 2, 4–8, all derived from b-ionone, another dou-
ble bond was clearly identiﬁed between C12 and C17 carbons,
while in compounds 1 and 3, both derived from a-ionone, C12
is sp3-hybridized and the cyclohexene double bond does occur
between C16 and C17 carbons.
Cyclohexene ring adopts half-chair and twist conforma-
tions in chalcones. Half-chair puckering is found in 1 and 3,
with C13 deviated by 0.598(7) A˚ and 0.486(4) A˚ from the
least-squares plane calculated through the other ﬁve cyclic
coplanar atoms (r.m.s.d. of the C12AC17AC16AC15AC14 ﬁt-
ted atoms is 0.0617 A˚ in 1 and 0.0889 A˚ in 3). However, C13 is
on the same side of C11 if the cyclohexene mean plane of 1 is
taken as reference, while these atoms are on opposite sides rel-
ative to the corresponding plane of 3. This conformational fea-
ture can be related to the equatorial position of C11 in 1 and
the axial one in 3 (see Fig. 1).
Just one twist conformation is observed in 4, with C14 and
C15 carbons deviating from the mean plane formed through
the C13AC12AC17AC16 atoms by 0.256(3) A˚ and 0.455(3)
A˚, respectively (r.m.s.d. of the ﬁtted atoms is 0.0293 A˚). This
twist conformation was also reported for the conformation
with minor occupancy of 2 (C14 and C15 deviations of 0.305
(18) A˚ and 0.170(12) A˚, r.m.s.d. of the ﬁtted coplanar atoms
is 0.0668 A˚). The other conformation was present with a half-
chair puckering with C15 at the ﬂap (C15 deviation of
0.467(13) A˚, r.m.s.d. of the ﬁtted coplanar atoms is 0.0384 A˚).Please cite this article in press as: Lima, R.S. et al., Structure and cytotoxic activity o
org/10.1016/j.arabjc.2016.02.013Similar to 4, cyclohexene ring of compounds 5–8 does
assume twist conformations with C14 and C15 carbons away
from the other four coplanar atoms. However, there are two
twist conformations featured by ﬂipping C14 and C15 carbons
in the last four terpenoid-like chalcones. In 6, C14 and C15
carbons are deviated by 0.276(13) A˚ and 0.501(12) A˚ from
the mean plane formed through the C13AC12AC17AC16
atoms (r.m.s.d. of the ﬁtted atoms is 0.0116 A˚) in one twist
conformation, and by 0.321(12) A˚ and 0.486(10) A˚ in
another one (r.m.s.d. of the C13AC12AC17AC16’ ﬁtted atoms
is 0.0020 A˚). Both twist conformations are equally distributed
over the crystal of 6, i.e., site occupancy factors of 50%
resulted in the best reﬁnement statistics. On contrary, the
major populations of 5 and 7 (both with 55% occupancy)
and 8 (65%) are present with a twist conformation featured
by C14 and C15 deviating 0.412(7) A˚ and 0.436(9) A˚ in 5,
0.35(2) A˚ and 0.558(11) A˚ in 7, and 0.325(11) A˚ and
0.443(11) A˚ in 8 from the least-square mean plane passing
through the four coplanar atoms (r.m.s.d. of the ﬁtted atoms
is 0.0209 A˚ in 5, 0.0177 A˚ in 7 and 0.0513 A˚ in 8). In the twist
conformation with minor occupancy of either 45% in 5 and 7
or 35% in 8, those respective carbons do deviate 0.447(9) A˚
and 0.412(11) A˚ in 5, 0.247(17) A˚ and 0.425(10) A˚ in 7, and
0.39(2) A˚ and 0.45(2) A˚ in 8 from the least-square mean
plane (r.m.s.d. of the ﬁtted atoms is 0.0208 A˚ in 5, 0.0204 A˚
in 7 and 0.0179 A˚ in 8).
Endocyclic torsion angles also describe the cyclohexene
conformations observed in terpenoid-like chalcones (Table 2).
The lowest dihedral angles within the cyclohexene are those on
the C15AC16 and C16AC17 bonds in the C13-ﬂap half-chair
conformation of 1 and 3 (torsions C14AC15AC16AC17 and
C12AC17AC16AC15). For the C15-ﬂap half-chair conforma-
tion of 2, the lowest dihedral angles into cyclohexene are those
on the C12AC13 and C12AC17 bonds (torsions
C17AC12AC13AC14 and C16AC17AC12AC13). Likewise,
the lowest endocyclic cyclohexene torsion angle is on the
C12AC17 bond in the twist conformation observed in 2, 4–8
(torsion C13AC12AC17AC16).
Another difference between the molecular conformations of
terpenoid-like chalcones resides in the C11AC12 bond axis
rotation, resulting in different orientations for cyclohexene
rings relative to core carbonyl and oleﬁn moieties. In chalcones
1 and 3 came from a-ionone, the cyclohexene mean plane, cal-
culated through coplanar carbon atoms, does form an angle of
ca. 90 [79.7(2) in 1 and 84.14(14) in 3] with the least-squares
mean plane encompassing carbonyl atoms and neighboring a-
carbons (r.m.s.d. of the ﬁtted C8, C9, C10 and O1 atoms is
0.0120 A˚ in 1 and 0.0030 A˚ in 3). Their C10AC11AC12AC13
and C10AC11AC12AC17 torsion angles are likewise similar
(Table 2). In the chalcones derived from b-ionone, the molec-
ular skeleton is not so bent as in those made up of a-ionone.
These corresponding mean planes are bent by 70(2) and 44
(3) in the major and minor populations of 2 (r.m.s.d. of the
ﬁtted C8, C9, C10 and O1 atoms is 0.0045), by 52.93(8) in 4
(r.m.s.d. of the ﬁtted C8, C9, C10 and O1 atoms is 0.0144),
by 5.39(15) in both major and minor populations of 5 (r.m.s.
d. of the ﬁtted C8, C9, C10 and O1 atoms is 0.0014), by
36.50(18) and 36.52(19) in the equally distributed popula-
tions of 6 (r.m.s.d. of the ﬁtted C8, C9, C10 and O1 atoms is
0.0151), by 37.9(2) in both major and minor populations of
7 (r.m.s.d. of the ﬁtted C8, C9, C10 and O1 atoms isf terpenoid-like chalcones. Arabian Journal of Chemistry (2016), http://dx.doi.
Table 1 Crystal data and reﬁnement statistics for the terpenoid-like chalcones prepared in this study.
1 3 4 5 6 7 8
Structural formula C20H23N1O3 C20H23N1O3 C20H23N1O3 C20H23N1O3 C20H23Br1O1 C20H23Cl1O1 C21H26O1
fw (g/mol) 325.39 325.39 325.39 325.39 359.29 314.83 294.42
Cryst dimensions (mm3) 0.30  0.15  0.05 0.20  0.12  0.05 0.30  0.10  0.07 0.24  0.11  0.010 0.26  0.14  0.06 0.32  0.10  0.08 0.20  0.11  0.08
Cryst syst Monoclinic Monoclinic Orthorhombic Monoclinic Monoclinic Monoclinic Orthorhombic
Space group P21/c P21/c Pbca P21/n P21 P21 Pbca
Z/Z0 4/1 4/1 8/1 4/1 2/1 2/1 8/1
T (K) 296(2) 296(2) 296(2) 296(2) 296(2) 296(2) 296(2)
Unit cell dimensions a (A˚) 11.861(2) 11.795(4) 15.0889(2) 7.2965(3) 8.0330(17) 7.9898(17) 15.205(2)
b (A˚) 14.277(2) 14.264(5) 10.65460(10) 19.3388(7) 10.228(2) 10.2912(17) 10.8720(15)
c (A˚) 10.9753(18) 11.053(4) 22.1010(3) 12.7689(5) 11.254(2) 11.196(3) 22.373(2)
a () 90 90 90 90 90 90 90
b () 97.551(2) 93.151(10) 90 92.895(3) 106.71(2) 106.966(10) 90
c () 90 90 90 90 90 90 90
V (A˚3) 1842.3(5) 1856.9(10) 3553.09(8) 1799.46(12) 885.6(3) 880.5(3) 3698.5(8)
Calculated density (Mg/m3) 1.173 1.164 1.217 1.201 1.347 1.187 1.058
Absorption coeﬃcient l (mm1) 0.078 0.078 0.081 0.080 2.321 0.217 0.063
h range for data collection () 3.34–25.74 2.33–26.62 1.84–26.45 1.91–25.24 2.65–25.70 2.67–25.64 1.82–25.35
Index ranges h 12 to 14 14 to 14 18 to 15 8 to 8 9 to 9 9 to 9 18 to 17
k 17 to 14 15 to 16 13 to 10 23 to 23 7 to 12 12 to 8 13 to 13
l 13 to 5 13 to 10 27 to 27 14 to 15 10 to 13 13 to 12 24 to 26
Data collected 7143 8991 26,159 12,033 4793 4218 22,665
Unique reﬂections 3477 3562 3654 3228 2566 2357 3368
Symmetry factor (Rint) 0.0252 0.0244 0.0236 0.0333 0.0227 0.0197 0.0741
Completeness to hmax (%) 98.6 94.9 (to 25) 99.7 99.2 97.5 98.2 99.6
F(000) 696 696 1392 696 372 336 1280
Parameters reﬁned 220 220 220 247 229 229 226
Goodness-of-ﬁt on F2 1.159 1.037 1.061 1.050 1.054 1.031 1.082
Final R1 factor for I> 2r(I) 0.1003 0.0816 0.0515 0.0504 0.0264 0.0364 0.0704
wR2 factor for all data 0.3421 0.2757 0.1623 0.1487 0.0678 0.0942 0.2637
Largest diﬀ. peak/hole (e/A˚3) 0.611/0.350 0.899/0.307 0.347/0.226 0.184/0.171 0.410/0.317 0.114/0.146 0.247/0.247
CCDC deposit number 1029766 1029767 1029768 1029769 1029770 1029771 1029772
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Figure 1 Asymmetric units of terpenoid-like chalcones crystallographically elucidated in this study. Non-hydrogen atoms are
represented as 30% probability ellipsoids, while hydrogens are shown as arbitrary radius spheres. Ellipsoids of the carbon fractions in
disordered positions of minor occupancy (or equal occupancy in 6) are drawn as boundaries, and open lines draw bonds between these
atom fractions.
Terpenoid-like chalcones 70.0258), and by 58.6(2) in both major and minor populations
of 8 (r.m.s.d. of the ﬁtted C8, C9, C10 and O1 atoms is 0.0126).
As can be viewed in Table 2, the C10AC11AC12AC13 tor-
sion angle of the b-ionone derived chalcones (except 5) is larger
than the corresponding ones of 1 and 3 whereas in turn their
C10AC11AC12AC17 torsion is lower than those of 1 and 3.
This reﬂects the fact that cyclohexene ring is less bent in b-
ionone-type compounds than in a-ionone derived chalcones
present with cyclohexene ring almost perpendicular to the core
molecular plane. This high planarity of b-ionone chalcones isPlease cite this article in press as: Lima, R.S. et al., Structure and cytotoxic activity o
org/10.1016/j.arabjc.2016.02.013highlighted in compound 5. Besides its lowest angle value
between the carbonyl/a-carbons and cyclohexene mean planes,
its C10AC11AC12AC13 and C10AC11AC12AC17 torsion
angles are close to 0 and 180, respectively (Table 2).
The central mean plane formed with carbonyl atoms and a-
carbons and the substituted aromatic ring are not much bent in
all terpenoid-like chalcones, forming angles between them of
37.53(14), 13.49(13), 2.59(12), 31.40(7), 22.46(9), 26.64
(9), 25.33(11), and 21.0(11) in 1–8, respectively. The torsions
around the C1AC7 bond axis are also near to either 0 (torsionf terpenoid-like chalcones. Arabian Journal of Chemistry (2016), http://dx.doi.
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org/10.1016/j.arabjc.2016.02.013C2AC1AC7AC8) or 180 (torsion C6AC1AC7AC8) in
terpenoid-like chalcones 1, 2, 4–8 and therefore reinforce the
coplanarity feature between aromatic ring and the a,b-
unsaturated carbonyl moiety. In terpenoid-like chalcone 3,
the torsion C6AC1AC7AC8 is close to 0 while the torsion
C2AC1AC7AC8 is near to 180. This indicates that such
coplanarity does also occur in this compound but it is present
with a rotation of ca. 180 about the C8AC9 bond axis relative
to all other terpenoid-like chalcones studied here (Fig. 2). The
torsions around this bond measure near to 180
(O1AC9AC8AC7) or 0 (C7AC8AC9AC10) in 3, while there
is inversion of their values in all other terpenoid-like chalcones,
i.e., O1AC9AC8AC7 and C7AC8AC9AC10 are close to 0
and 180, respectively (Table 2). Likewise, the torsions on
the C9AC10 bond are similar in 2, 3 and 5, but their values
are changed by ca. 180 in the other terpenoid-like chalcones
(Table 2). Therefore, a twofold rotation on the C9AC10 bond
axis can be also described for these compounds when com-
pared to terpenoid-like chalcones 1, 4, 6–8 (Fig. 2). It is also
noticeable the high coplanarity between aromatic ring and
the a,b-unsaturated carbonyl moiety in compound 3 due to
the negligible value of the angle between their least-square
planes.
Nitro group is noticeably twisted only in compound 5, with
its plane forming an angle of 38.41(7) with the phenyl mean
plane. In all other nitro-substituted terpenoid-like chalcones,
these two moieties are considerably coplanar with angles
between them of 12.9(4), 7.3(3), 7.8(3), and 4.82(17) in 1–
4, respectively. In addition, inspection of bond lengths indi-
cates that electron delocalization does not encompass the
molecule backbone of all chalcones (Table 3). Bond lengths
of the a,b-unsaturated carbonyl moiety and of the bridges
between this moiety and six-membered rings are in good agree-
ment with expected values for pure single and double bonds.
3.2. Cytotoxic activity
All synthesized terpenoid-like-chalcones were evaluated for
their in vitro cytotoxic activity against three human cancer cell
lines (SF-295, HCT-116 and OVCAR-8). The antiproliferative
activity assay results are shown in Tables 4 and 5.
As can be viewed in Table 4, terpenoid-like chalcones have
almost entirely inhibited all cancer cell lines tested, except for
compounds 4 and 6 inhibiting ca. 60% the SF-295 cell line and
compound 5 inhibiting also ca. 60% the HCT-116 cell line.
Therefore, a very broad spectrum of antiproliferative effects
was observed for all compounds. In concentration of 50 lg/
ml, the compounds displayed signiﬁcant antiproliferative
effects against SF-295, HCT-116 and OVCAR-8 cell lines.
The relative potency of cell growth inhibition is shown in
Table 5 in which as low the IC50 value of a terpenoid-like chal-
cone as high its cytotoxic activity. It is noteworthy that com-
pounds 1 and 5 possess antiproliferative effect against HCT-
116 cells. In fact, compounds 1 and 2, both of them with
para-nitro moiety and derived from a- and b-ionone, respec-
tively, and compound 3, with meta-nitro group and derived
from a-ionone, and compound 5, with ortho-nitro group and
derived from b-ionone, were notably the most active
terpenoid-like chalcones among all those tested. Their IC50
values range from 2.88 to 10.84 lmol/L (compound 1), from
3.99 to 10.26 lmol/L (compound 2), from 4.33 to 6.20 lmol/f terpenoid-like chalcones. Arabian Journal of Chemistry (2016), http://dx.doi.
Figure 2 Molecular overlay through carbonyl atoms and neighboring a-carbons of (A) compounds 1 (green) and 3 (blue); and (B)
compounds 2 (yellow) and 3 (blue). The 180 rotations on the C8AC9 and C9AC10 bond axes converting one molecule conformation into
another one are highlighted (circular arrows). (C) Selected torsions describing the conformations around C8AC9 and C9AC10 bonds
found in the chalcone derivatives studied here.
Terpenoid-like chalcones 9L (compound 3), and from 2.70 to 8.85 lmol/L (compound 5).
Compound 4 with meta-nitro group and derived from
b-ionone was slightly less active than all other
nitro-substituted analogs (IC50 ranging from 5.22 to
20.28 lmol/L). This reveals the presence of one nitro moiety
at any position of aromatic ring is decisive for antiproliferativePlease cite this article in press as: Lima, R.S. et al., Structure and cytotoxic activity o
org/10.1016/j.arabjc.2016.02.013activity of the terpenoid-like chalcones, whereas cyclohexene
type does not affect much cytotoxic activity. Against other
cancer lines, such as prostate (PC-3), breast (MCF), central
nervous system (IMR32), and cervix (HeLa), the presence of
one nitro group at para position of phenyl increases much
the cytotoxicity of the b-ionone derived chalcone 2a (Sharmaf terpenoid-like chalcones. Arabian Journal of Chemistry (2016), http://dx.doi.
Table 3 Selected bond lengths (A˚) for terpenoid-like chalcones 1–8.
Bond 1 2a 3 4 5a 6 7 8
O1AC9 1.225(4) 1.228(3) 1.221(3) 1.225(2) 1.224(3) 1.219(4) 1.230(4) 1.236(4)
C1AC7 1.466(4) 1.461(4) 1.468(3) 1.467(2) 1.467(3) 1.458(4) 1.465(4) 1.463(4)
C7AC8 1.316(4) 1.314(4) 1.307(3) 1.318(2) 1.321(3) 1.315(4) 1.314(4) 1.318(4)
C8AC9 1.480(4) 1.474(4) 1.475(4) 1.477(2) 1.477(3) 1.471(4) 1.469(4) 1.471(4)
C9AC10 1.454(5) 1.459(4) 1.464(4) 1.463(2) 1.467(3) 1.477(4) 1.471(4) 1.459(4)
C10AC11 1.306(4) 1.323(4) 1.307(4) 1.322(3) 1.326(3) 1.319(4) 1.311(4) 1.319(4)
C11AC12 1.485(6) 1.496(16) 1.496(4) 1.471(2) 1.455(3) 1.478(4) 1.482(4) 1.468(4)
a Compounds 2 and 5 have been previously synthesized and featured (Zou et al., 2012; Fernandes et al., 2013), even though crystal data of 5
are from our structure redetermination.
Table 4 Cytotoxicity of terpenoid-like chalcones against three
tumor cell lines.a,b
Compound SF-295 HTC-116 OVCAR-8
1 99.09 ± 1.40 100 ± 0.58 99.93 ± 0.28
2 99.21 ± 0.00 99.54 ± 0.51 99.41 ± 0.64
3 99.53 ± 0.22 98.46 ± 0.15 97.85 ± 1.01
4 62.29 ± 5.87 99.59 ± 0.58 98.50 ± 0.83
5 99.25 ± 0.50 59.44 ± 0.00 95.97 ±4.05
6 60.75 ± 4.61 100 ± 0.58 99.80 ± 1.93
7 98.42 ± 0.56 96.35 ± 1.09 94.53 ± 4.60
8 97.98 ± 1.62 99.38 ± 0.58 98.76 ± 0.83
Dexorrubicinc 97.40 ± 0.10 98.55 ± 0.13 99.00 ± 0.10
a Cancer cell lines: SF-295, central nervous system. HTC-116,
colon cancer and OVCAR-8, breast cancer.
b Cell-growth inhibition percentage (GI-%) was measured at a
compound concentration of 25 lg/mL and is shown as the average
of three replicates followed by standard deviation.
c Positive control at 5 lg/mL.
10 R.S. Lima et al.et al., 2013), which did also occur in another chalcone with two
phenyl moieties (bearing three methoxy groups in the B-ring
and one para-nitro group in the A-ring) (Bandgar et al.,
2010). The presence of nitro moiety in the 2-position of phenyl
rings has been likewise responsible to improve the anticancer
activity of curcumin related compounds similar to chalcones
(Bukhari et al., 2014a).
The inspection of IC50 values does also show another inter-
esting structure–activity relationship. There is a trend of
decrease in cytotoxic activity with weak electron-withdrawing
groups at phenyl ring. This has been reported previously forTable 5 IC50 values of terpenoid-like chalcones against three cance
Compound SF-295
1 10.84 (8.94–13.15)
2 3.99 (2.79–5.74)
3 6.20 (4.54–8.45)
4 20.28 (13.58–30.30)
5 8.85 (6.64–11.83)
6 19.28 (13.91–26.69)
7 22.61 (19.63–26.11)
8 35.39 (32.19–38.85)
Doxorrubicinc 0.44 (0.37–0.49)
a Cancer cell lines: SF-295, central nervous system. HTC-116, colon ca
b IC50 (CI 95%) [lmol/L]: 50% inhibitory concentration and 95% con
c Positive control.
Please cite this article in press as: Lima, R.S. et al., Structure and cytotoxic activity o
org/10.1016/j.arabjc.2016.02.013anticancer (Singh et al., 2014; Bandgar et al., 2010) and anti-
inﬂammatory properties of chalcones (Bukhari et al., 2012).
More precisely, the presence and strength of electron with-
drawing groups in the phenyl ring of b-ionone derived chal-
cones have been found to be decisive for their cytotoxicity
(Sharma et al., 2013) as well as in methoxychalcones (Singh
et al., 2014; Bandgar et al., 2010). In agreement with these pre-
vious ﬁndings, the presence of either bromine or chlorine,
which are less electron-withdrawing than nitro moiety, at
para-position does decreases cytotoxic activity of terpenoid-
like chalcones 6 and 7 (IC50 ranging from 12.55 to
19.28 lmol/L for compound 6 and from 9.27 to 22.61 lmol/
L for compound 7) relative to nitro derivatives 1 and 2. Similar
IC50 values have been found for related halogenated chalcones
bearing two phenyl moieties bonded at 1,3-positions of prop-2-
en-1-one (Dias et al., 2013). Chalcones with ortho-
hydroxyphenyl group bonded to carbonyl carbon and one
either meta or para halogenated (F, Cl or Br) phenyl ring
bonded to b-carbon have shown IC50 values in the 10.9–
20.9 lmol/L range against colorectal carcinoma cell line
HCT-116 (Dias et al., 2013). Also, ortho-hydroxychalcones
with halogen substitution at para position were less active than
those halogenated at meta position. Against the same cell line
HCT-116, para-halogenated ortho-hydroxychalcones with Br
and Cl had similar IC50 values of 19.1 and 20.9 lmol/L
(Dias et al., 2013), whereas these average values for our related
compounds 6 and 7 were 19.23 and 9.27 lmol/L. This indicates
that b-ionone and a further a,b-unsaturated set of carbons can
increase anticancer activity from Br to Cl. Similar trend of
increasing cytotoxicity as halogen substitution in the ortho-
position of the phenyl ring bonded to b-carbon goes from Brr cell lines.a,b
HTC-116 OVCAR-8
2.88 (2.27–3.68) 6.33 (5.32–7.49)
10.26 (8.75–12.05) 4.39 (3.96–4.85)
4.48 (3.50–5.71) 4.33 (3.78–4.97)
5.22 (4.91–5.56) 7.19 (6.20–8.17)
2.70 (2.21–3.26) 6.36 (5.62–7.19)
19.23 (14.44–26.60) 12.55 (10.60–14.86)
9.27 (7.46–11.53) 12.64 (10.83–14.71)
15.86 (11.37–22.08) 32.19 (28.49–36.37)
0.22 (0.17–0.31) 0.48 (0.31–0.55)
ncer and OVCAR-8, breast cancer.
ﬁdence interval.
f terpenoid-like chalcones. Arabian Journal of Chemistry (2016), http://dx.doi.
Terpenoid-like chalcones 11to F was also observed in chalcones with 1,3-diphenyl moieties
against a colon cell line (COLO-205) (Jain et al., 2014). Such
an increasing was followed by the increase in the lipophilicity
of the substituent in the para-position of phenyl ring bonded
to carbonyl carbon from methoxy to phenoxy (Jain et al.,
2014). When compared with the cytotoxic proﬁle of com-
pounds 6 and 7 against a colorectal cell line, it appears that this
biological activity of chalcones increases as the lipophilicity of
the moiety neighbor to carbonyl and as electron-withdrawing
strength of one halogen in the phenyl ring attached at the other
tail of prop-2-en-1-one, regardless of its position.
In our compounds, antiproliferative effect reduction is still
highlighted in compound 8 present with para-methyl moiety
(IC50 ranging from 15.86 to 35.39 lmol/L). Indeed, this last
compound was the less active terpenoid-like chalcone against
all cancer cell lines.
Several articles show the anticancer potential of chalcones
and their derivatives with selectivity for cancer cells, demon-
strating the therapeutic potential of this chemical class
(Jandial et al., 2014). Champelovier et al. (2013) showed selec-
tivity of two chalcones (A and B) for the LN229 lineage
(glioblastoma tumor cells) relative to the mononuclear cells
from peripheral blood and skin ﬁbroblasts. Both chalcones
were able to cause intracellular oxidative stress, accumulation
of cells in G2/M, besides chalcone A activating the caspase
apoptotic pathway and chalcone B inducing cell death by
autophagy without affecting proliferation of normal cells.
Tang et al. (2010) also showed that the compound ﬂa-
vokawain B, the chalcone kava, was effective in reducing the
viability of cell lines DU145, PC3, LAPC4 and LNCaP, all
strains of prostate cancer, with minimal cytotoxicity against
normal cells from prostate epithelium and stroma. In cancer
cells, this chalcone induces apoptosis by increasing the expres-
sion of pro-apoptotic proteins such as death receptor-5, Bim
and Puma and by decreasing the expression of the apoptosis
inhibitors such as XIAP and survivin.
In another work, the series of boronic-chalcone derivatives
were synthesized and shown to be effective in inhibiting the pro-
liferation of breast cancer cells at micromolar concentrations
(MDA-MB-435,MDA-MB-231,Wt,MCF7), without affecting
the viability and proliferation of normal mammary epithelial
cells, MCF-10A and MCF-12A (Kumar et al., 2003). Further-
more, it was shown that indanocine, a chalcone-like compound,
is an antimitotic and cytotoxic compound that blocks the poly-
merization of tubulin, inducing cell death by apoptosis in cancer
cells resistant to multiple drugs at concentrations that are non-
cytotoxic to non-carcinogenic cells (Leoni et al., 2000).
These literature data therefore reveal that besides synthetic
chalcones having anticancer potential, many compounds of
this class exhibit selectivity for tumor cells, which allow us to
believe that the compounds reported in this study can also
show selectivity for the cancer cells such as SF-295, HCT-
116 and OVCAR-8 assessed here. So we can infer that the
compounds derived from chalcones, as terpenoid-like chal-
cones, are promising for the development of new drugs to ﬁght
cancer.
4. Conclusions
Eight compounds with both ionone and chalcone cores were synthe-
sized in this study. The Claisen–Schmidt condensation was employed
using either a- or b-ionone and substituted benzaldehydes. ThePlease cite this article in press as: Lima, R.S. et al., Structure and cytotoxic activity o
org/10.1016/j.arabjc.2016.02.013structures of six compounds were elucidated by single-crystal X-ray
diffraction technique for the ﬁrst time. Detailed crystal structure
inspection, including the analysis of other related terpenoid-like chal-
cones whose structures are already reported in the literature, has
revealed interesting conformational features such as cyclohexene ring
adopting half-chair conformation with C13 at the ﬂap only in a-
ionone type chalcones. On the other hand, twist puckering of cyclohex-
ene with C14 and C15 deviating from the other coplanar carbons is
commonly found in b-ionone chalcones including conformerism fea-
tured by the ﬂipping of these carbons in a same structure. Further-
more, a-ionone derived chalcones are present with cyclohexene ring
almost perpendicular to the a,b-unsaturated carbonyl mean plane,
while the last plane and the substituted aromatic ring are not much
bent in all terpenoid-like chalcones. There is also a rotation of ca.
180 about the C8AC9 bond axis of the a-ionone-type chalcone with
nitro moiety at meta-position of phenyl if all other terpenoid-like chal-
cones studied here were taken as references. Likewise, terpenoid-like
chalcones can also adopt two different conformations due to a 180
rotation on the C9AC10 bond axis.
All compounds synthesized in this study and another related
terpenoid-like chalcone were also evaluated for their cytotoxic activity
against three cancer cell lines (SF-295, HCT-116 and OVCAR-8),
being observed a very broad spectrum of antiproliferative effects.
Moreover, compounds with nitro group in phenyl, regardless of its
position, and derived from either a- or b-ionone were the most active
terpenoid-like chalcones among all those tested, revealing that the
presence of one nitro moiety is decisive for cytotoxicity of the
terpenoid-like chalcones whereas cyclohexene type does not affect
much this biological property. The tendency of decrease in cytotoxic
activity with weak electron-withdrawing groups at phenyl ring was also
supported on the basis of IC50 values.
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